TrialCancer medicine2026

Phase II Trial of Opaganib Addition in Metastatic Castration-Resistant Prostate Cancer After Disease Progression on Abiraterone or Enzalutamide.

Jacqueline T Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.